Welcome to our dedicated page for AUNA S.A. SEC filings (Ticker: AUNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Auna S.A.'s SEC filings document a foreign private issuer operating a healthcare services and health-plan platform in Mexico, Peru and Colombia. Current reports on Form 6-K furnish press releases, IFRS financial statements, operating KPIs, annual Form 20-F availability, and updates on healthcare services in Peru, Colombia and Mexico and Oncosalud Peru.
The filing record also covers capital-structure matters, including senior secured notes and completed debt refinancing, as well as material project and agreement disclosures related to the Torre Trecca public-private partnership. These documents frame Auna's results, leverage, segment activity and corporate reporting obligations under its NYSE-listed issuer structure.
AUNA S.A. (AUNA) reported 2Q26 results showing solid growth but weaker margins and earnings. Revenue rose 13% year over year to S/1,238 million (9% FX-neutral), with all three geographies (Mexico, Peru, Colombia) growing in local currency, led by Colombia’s 13% increase and Peru’s 8% gain.
Adjusted EBITDA declined 6% to S/227 million, and margin compressed to 18.4% from 22.1%, reflecting service mix, higher pharmacy, payroll and nursing costs, and accepted billing-related penalties in Peru. Net income dropped to S/33 million from 84 million, mainly due to a much smaller positive FX impact in finance costs; Adjusted Net Income fell to S/40 million from 89 million.
Cash generation was strong: year-to-date operating cash flow increased 76% to S/441 million, and free cash flow reached S/400 million versus 143 million a year earlier. Net debt declined to S/3,252 million and the leverage ratio remained at 3.6x, while management reaffirmed 2026 FX-neutral revenue growth guidance near 12% and expects Adjusted EBITDA growth at the low end of its 10–14% range, with capex around 4% of revenues.
Teacher Retirement System of Texas filed an amended Schedule 13G reporting its passive ownership in AUNA S.A.. As of the close of business on April 14, 2026, it beneficially owned 1,504,140 Class A Ordinary Shares, with a par value of $0.01 per share. This position represents 4.99% of AUNA’s Class A Ordinary Shares outstanding, based on 30,095,388 shares outstanding as of December 31, 2025, as reported in AUNA’s Form 20-F. The fund reports sole voting and dispositive power over all 1,504,140 shares and no shared voting or dispositive power, and notes that it now holds 5 percent or less of this class.
Auna S.A. reported preliminary key performance indicators for the second quarter ended June 30, 2026 across its healthcare operations in Mexico, Peru and Colombia. Metrics include emergency treatments, surgeries, days hospitalized, chemotherapies and radiotherapies, plan memberships and protected lives under risk-sharing agreements.
In 2Q 2026, Healthcare Services Peru recorded 51,769 emergency treatments and capacity utilization of 80.2%, while Healthcare Services Colombia reported 3,143,694 protected lives and capacity utilization of 79.2%. As of June 30, 2026, Auna operated 31 facilities with 2,337 beds and 1.4 million health plan members. These indicators are preliminary and subject to revision.
RWC Asset Management LLP reported beneficial ownership of 1,520,929 shares of AUNA, S.A., representing 5.05% of the class as of 06/30/2026. The filing is an amended Schedule 13G/A (Amendment No. 8) and shows RWC holds sole voting and dispositive power over the reported shares.
Auna S.A. reported the results of its annual general meeting, where shareholders approved all matters presented to them. The company also updated its board structure, setting the board at seven members after Jorge Basadre and Guadalupe Phillips stepped down, with the vacancies not being filled for now. Following these changes, the board still has a majority of independent directors. As of March 31, 2026, Auna’s Latin American healthcare platform included 31 facilities with 2,337 beds and 1.4 million health plan members.
AUNA S.A.’s president and director Jesus Zamora León reported open-market purchases of 51,454 Class A Common Shares between May 20 and May 29, 2026, at prices between $4.15 and $4.39 per share.
Following these transactions, he holds 69,130 Class A shares directly and 55,134 Class A shares indirectly through Enfoca Ltd. He is also indirectly associated with 32,029,016 Class B common shares held by the Enfoca Entities, each convertible into one Class A share under the issuer’s articles. The filing notes it was inadvertently filed late due to an administrative error.
AUNA S.A. director Wilton John sold 17,574 Class A Common Shares in an open-market transaction. The weighted average sale price was $4.1711 per share, with individual trades between $4.1700 and $4.2001. Following the sale, he directly owns 49,974 Class A Common Shares.
AUNA S.A. director and president Zamora Leon Jesus filed an amended Form 3 showing his existing ownership, not new trades. He indirectly holds 32,029,016 Class B common shares through Enfoca entities and indirectly holds 10,100 Class A common shares through Enfoca Ltd.
He also directly owns 30,710 Class A common shares. In addition, he holds share options over 209,677 Class A common shares at an exercise price of $6.32, plus performance share options over 277,778 shares at $6.32 and 2,217,528 shares at $12.00, all with long-dated expirations and vesting tied to future share-price and time-based conditions.
AUNA S.A. ownership filing: Daniel Kaufman reports beneficial ownership of 1,827,749 Class A Ordinary Shares, representing 6.1% of the class.
The filing cites 30,138,747 Class A Ordinary Shares outstanding as of April 9, 2026 from the issuer's 20-F. Kaufman reports sole voting and dispositive power over the shares.
AUNA S.A. President and director Zamora Leon Jesus bought Class A Common Shares in open-market transactions. He purchased 8,727 Class A shares on May 26, 2026 at a weighted average price of $4.2389 per share and 23,273 Class A shares on May 27, 2026 at a weighted average price of $4.1981 per share, totaling 32,000 shares. After these purchases, he directly owns 62,710 Class A shares.
He is also reported as indirectly owning 32,029,016 Class B common shares through the Enfoca Entities. Each Class B common share is convertible into one Class A common share. The reported prices reflect multiple trades within ranges from $4.17 to $4.24 per share.